Sort
21,453 grants matching “tuberculosis”
Bacterial Mechanisms and Host Pharmacokinetic Factors that Determine Persistence
$385,878Veronique Dartois · Rbhs-New Jersey Medical School · U19 · FY2018 · AI
Pathogenic Mycobacterial Proteins in Sarcoidosis
$385,759David R Moller · Johns Hopkins University · R01 · FY2006 · HL
Structure and function of ClpXP
$385,688Robert T Sauer · Massachusetts Institute Of Technology · R35 · FY2021 · GM
Impact of Tuberculosis on HIV Disease
$385,679Zahra Toossi · Case Western Reserve University · R01 · FY2010 · HL
M TUBERCULOSIS SIGH AND ITS REGULON IN THE IMMUNOPATHOLOGY OF TUBERCULOSIS
$385,673Deepak Kaushal · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2010 · RR
Differentiation and function of intestinal tissue-resident memory T cells
$385,561Tessa Bergsbaken · Rbhs-New Jersey Medical School · R01 · FY2020 · AI
Molecular Imaging for Macrophage-Associated Pulmonary Inflammation
$385,560Sanjay Jain · Johns Hopkins University · R01 · FY2013 · HL
Altered M. tuberculosis Mannosylation and the Macrophage
$385,521Larry S. Schlesinger · Ohio State University · R01 · FY2006 · AI
Metabolic regulation of macrophage function during M. tuberculosis infection
$385,512Sarah A Stanley · University Of California Berkeley · R01 · FY2020 · AI
"Genetic Approaches for Improving Tuberculosis Vaccines"
$385,499William Robert Jacobs · Albert Einstein College Of Medicine, Inc · P01 · FY2015 · AI
Molecular and Cell Biology in Environmental Medicine
$385,359New York University School Of Medicine · T32 · FY2002 · ES
Novel fluoroquinolones for killing dormant Mycobacterium tuberculosis
$385,234Karl A Drlica · Rbhs-New Jersey Medical School · R01 · FY2014 · AI
Novel fluoroquinolones for killing dormant Mycobacterium tuberculosis
$385,234Karl A Drlica · Rbhs-New Jersey Medical School · R01 · FY2015 · AI
Haitian Program for Research and Training in HIV/AIDS
$385,224Jean William Pape · Gheskio Center · U01 · FY2009 · AI
BU Clinical HIV/AIDS Research Training Program
$385,184Benjamin P Linas · Boston Medical Center · T32 · FY2019 · AI
SCREEN DEVELOPMENT FOR ANTIMICROBIAL PRODRUGS
$385,043Kim Lewis · Northeastern University · R01 · FY2009 · AI
SCREEN DEVELOPMENT FOR ANTIMICROBIAL PRODRUGS
$385,043Kim Lewis · Northeastern University · R01 · FY2008 · AI
Host Responses to Mycobacterium Infection in Zebrafish
$385,039Lalita Ramakrishnan · University Of Washington · R01 · FY2007 · AI
Novel Reporter Phages to Detect Complex TB Drug Resistance and Persistence
$385,037Michelle H Larsen · Albert Einstein College Of Medicine · R01 · FY2018 · AI
Antibacterial Methionine Aminopeptidase Inhibitors
$385,000Qi-Zhuang Ye · Indiana University Indianapolis · R56 · FY2010 · AI
Role of Vitamin D Prohormone 25-OHD in the Innate Immune Response to Tuberculosis
$385,000Robert L Modlin · University Of California Los Angeles · R01 · FY2009 · AI
Linked: HIV-Associated Malignancies in Malawi
$385,000Steve Kamiza · University Of Malawi · R24 · FY2014 · TW
TB Membrane Transporters and Intrinsic Resistance
$385,000Georgiana E Purdy · Oregon Health & Science University · R01 · FY2015 · AI
TB Membrane Transporters and Intrinsic Resistance
$385,000Georgiana E Purdy · Oregon Health & Science University · R01 · FY2014 · AI
Regulation of human IL12/IL23 responsiveness by IL12RB1
$385,000Richard Robinson · Medical College Of Wisconsin · R01 · FY2017 · AI